Skip to content
healthcare.dev

FYARRO

NDC 80803-153, Sirolimus, injection, powder, lyophilized, for suspension, from Aadi Bioscience, Inc..

Product NDC
80803-153
Status
Listed
Labeler
Aadi Bioscience, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213312
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80803-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SIROLIMUS5 mg/mL

Pharmacologic classes

Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
80803-153-50808030153501 VIAL, SINGLE-USE in 1 CARTON (80803-153-50) / 20 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0f9bb784-53e2-46f9-a65d-1c6c2a230eaf
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=80803-153

Use it

Look up 80803-153 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80803-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80803-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.